2-(2-Aminothiazole-4-Yl)-(Z)-2-(Methoxycarbonylmethoxyimino)Acetic Acid

Cefixime trihydrate manufacturing relies on the acylation of a 7-aminocephalosporanic acid derivative with an activated side-chain acid, and the intermediate 2-(2-Aminothiazole-4-Yl)-(Z)-2-(Methoxycarbonylmethoxyimino)Acetic Acid (synonym: (Z)-2-(2-aminothiazol-4-yl)-2-(methoxycarbonylmethoxyimino)acetic acid; CAS 86252-74-6) serves as the critical (Z)-oxime acid building block. The molecular formula is C₉H₉N₃O₅S with a formula weight of 287.25 g·mol⁻¹. The compound crystallises as a white to off-white powder, exhibiting a melting point range of 178–182°C (decomposition). Its role in third-generation cephalosporin synthesis demands exceptionally narrow purity windows, as even 0.2% of the (E)-anti isomer can shift the diastereomeric ratio in the final active pharmaceutical ingredient (API) outside pharmacopoeial limits. Production-scale batches of this intermediate are typically manufactured in 2000–5000 L glass-lined reactors via oximation of ethyl 2-(2-aminothiazol-4-yl)-2-(hydroxyimino)acetate with methyl chloroacetate, followed by controlled alkaline hydrolysis of the ester group without disturbing the sensitive thiazole ring.

Critical Impurity Thresholds and Coupling Yield Variances

High-performance liquid chromatography (HPLC) purity, determined on a C18 column (250 × 4.6 mm, 5 µm) with a phosphate buffer–acetonitrile mobile phase at 1.0 mL·min⁻¹ and UV detection at 254 nm, constitutes the primary release criterion. The (Z)-isomer content must exceed 99.5% area percent; at 99.8%, the mixed anhydride coupling with 7-AVCA yields cefixime trihydrate at ≥88% molar yield. When the (Z)-ratio declines to 99.0%, coupling efficiency drops to below 78% under identical activation conditions (pivaloyl chloride, triethylamine, dichloromethane, −15 to −5°C). The resulting crude API then requires an additional re-precipitation step, increasing solvent consumption by approximately 35% and extending cycle time by 8–12 hours in a 3000 L isolator-equipped centrifuge train. Individual related substances are capped at 0.10% for the (E)-anti isomer and 0.15% for the 2-(2-aminothiazol-4-yl)glyoxylic acid hydrolysis byproduct; any single unknown impurity must not exceed 0.10%. A key in-process control during the hydrolysis stage involves monitoring pH at 10.5 ± 0.3 and temperature at 20 ± 2°C, as alkaline overexposure isomerises the oxime geometry and generates the anti-isomer at a rate of roughly 0.05%·h⁻¹.

In the synthesis of cefixime trihydrate, the acid is activated as a mixed anhydride with pivaloyl chloride in the presence of a tertiary amine; residual water above 0.3% w/w in the solid intermediate leads to anhydride hydrolysis and the formation of the free acid dimer, detectable as a late-eluting peak at relative retention time 1.45 against the parent compound. This side reaction depletes the active acylating agent and decreases the isolated yield of cefixime by 2–4% per 0.1% increment in moisture. Production facilities that pre-dry the wet cake in a double-cone rotary vacuum dryer at 40°C and 10 mbar for 16 hours routinely achieve LOD values of 0.15–0.25%, whereas tray drying under static vacuum at the same temperature often retains residual moisture of 0.4–0.6%, requiring an additional 4-hour post-drying pass under nitrogen sweep. No processing aid residue is tolerated; filtration through 0.5 µm polypropylene cloth followed by a water-miscible solvent wash (typically chilled acetone) removes water-soluble oligomers before the drying cycle.

What Limits LOD Specification to ≤0.5% After Vacuum Tray Drying?

The moisture limit is not solely driven by the hydrolysis of the activated anhydride; it also governs bulk powder flow in automated dispensing systems used for solid-phase acylation campaigns. When the water content exceeds 0.5% w/w, the powder transitions from a free-flowing crystalline solid (Carr index 12–15) to a cohesive mass with a measured Carr index of 22–26, causing bridging in vibratory feeders calibrated for 1.0 kg·h⁻¹ continuous addition to the reactor. Loss-on-drying values are correlated with Karl Fischer titrations for every production batch; the oven method at 60°C underestimates water by 0.08–0.12% because of thermal decarboxylation artefacts, necessitating the Karl Fischer procedure specified in the monograph. Humidity exposure during dispensing is controlled by maintaining the weigh-room relative humidity below 30% and performing the transfer under dry nitrogen purge; even a 15-minute exposure to 55% RH increases water uptake by 0.07%, sufficient to push a borderline batch out of specification.

Process behaviour of the oxime acid diverges markedly from the corresponding ethyl ester analog, ethyl (Z)-2-(2-aminothiazol-4-yl)-2-(methoxycarbonylmethoxyimino)acetate (CAS 64485-82-1), which is the preferred intermediate for ceftazidime side-chain construction. The free acid eliminates the need for alkaline ester hydrolysis after coupling, thereby avoiding the ring-opening of the β-lactam that can occur at pH above 8.5 during ceftazidime finishing. However, the free acid displays a stark solubility limitation: it dissolves at only 8–12 mg·mL⁻¹ in dichloromethane at 20°C versus more than 150 mg·mL⁻¹ for the ethyl ester, compelling a suspension-based activation or a switch to dimethylacetamide as co-solvent. The resulting heterogeneous mixed anhydride formation requires extended ageing times (90–120 minutes) and precise stoichiometric control of pivaloyl chloride (1.05 eq.) to avoid unreacted acid carryover that would contaminate the cephalosporin nucleus. When the process is transferred from the ethyl ester to the free acid, plant engineers must retrofit the reactor charge lines with heated jackets to keep the solvent at 30–35°C and install a recirculation loop through an in-line 50 μm filter to prevent insoluble acid particles from entering the acylation vessel.

When the Anti-Isomer Content Climbs Beyond 0.3% in Cefpodoxime Proxetil Synthesis

Though the (Z)-methoxycarbonylmethoxyimino acetic acid is primarily associated with cefixime production, it also serves as the side-chain precursor for cefpodoxime proxetil synthesis. In this route, the acid is first converted to its activated thioester. The anti-isomer tolerance is even tighter in cefpodoxime because the (E)-configured prodrug shows a crystallisation tendency that leads to turbid reconstituted suspensions. Batches with an anti-isomer content of 0.35–0.50% have been documented to fail the clarity specification (absorbance ≤0.10 at 420 nm per in-house method) in the finished oral suspension, triggering batch rejection at the formulated product stage. To maintain the anti-isomer below 0.20%, manufacturers implement a terminal recrystallisation from acetone/water (85:15 v/v) with a cooling gradient of 0.1°C·min⁻¹ from 48°C to 15°C, which selectively enriches the mother liquors in the anti-isomer. This step consumes approximately 10 volumes of acetone per kilogram of crude acid and extends the total batch lead time by 48 hours, yet it is unavoidable when the crude (Z)-ratio falls below 99.3%.

Comparison of the methoxycarbonylmethoxyimino acid with other aminothiazole oxime acids used in cephalosporin side chains clarifies its specific design. The following table contrasts the product with its ethyl ester analog and the closely related (Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetic acid, which is the side-chain acid for cefotaxime and ceftriaxone.

Operationally, the carboxymethoxyimino substituent in ATMA acid imparts a tendency to form insoluble calcium salts if exposed to hard water during washing steps, a characteristic not observed with the methoxyimino analog. In continuous manufacturing campaigns, this behaviour manifests as gradual scaling on the inner walls of stainless steel centrifuges (UNS S31603) and requires periodic acid cleaning with dilute nitric acid (5% v/v) every 40 batches to restore heat transfer rates. The ethyl ester bypasses this issue entirely but introduces an additional saponification step after coupling that generates up to 0.5 kg of sodium salt waste per kg of API, which must be treated before discharge under local environmental permits. Process selection between the free acid and its ester therefore depends on the trade-off between isolator downtime from scaling and the cost of alkaline waste neutralisation.

The compound is incompatible with strong bases and primary amines; exposure to morpholine or piperidine at ambient temperature results in oxime cleavage and thiazole ring opening within 30 minutes, rendering the batch unrecoverable. Consequently, dedicated acid-resistant transfer lines (PTFE-lined braided hose) and glass-lined storage vessels are mandated, and all cleaning solvents must be verified free of amine alkalinity prior to use. In one documented plant deviation, residual triethylamine from a preceding ceftazidime campaign was not adequately flushed from a shared receiver, causing a 7% loss in ATMA acid assay when the first lot was held for 6 hours pending QC release. The root cause investigation led to the installation of segregated hard-piped manifolds for aminothiazole acids and a mandatory pH check (target 6.0–7.0) on the final solvent rinse fraction.